Skip to main content

URMC Logo

URMC / Research / Research@URMC
New Study Focuses on HIV Care in Africa

New Study Focuses on HIV Care in Africa

A new $2.9 million grant will seek to better understand the risk and potential negative drug interactions experienced by people living with HIV-associated seizures in Africa.

10/30/2015
Getting a Flu Shot? Skip the Advil, Tylenol, for Mild Discomfort

Getting a Flu Shot? Skip the Advil, Tylenol, for Mild Discomfort

Each year during flu season we check in with URMC scientist Rick Phipps to find out if his evidence-based advice holds true—and it still does: It’s best to avoid common pain relievers after a flu shot because they can dilute the power of the vaccine.

10/15/2015
Repurposed Drug Reduces Agitation in Alzheimer’s Patients

Repurposed Drug Reduces Agitation in Alzheimer’s Patients

A URMC psychiatrist was recently involved in a clinical study showing that a drug currently marketed under the trade name Nuedexta reduces agitation in Alzheimer’s disease patients and eases caregiver burden.

10/13/2015
Study Finds Link Between Rare Genetic Mutation and Osteoporosis

Study Finds Link Between Rare Genetic Mutation and Osteoporosis

A URMC scientist recently contributed to a large genetic study that found a link between a rare genetic mutation and osteoporosis.  These findings suggest there may be one hundred different types of osteoporosis that may need to be treated one hundred different ways. 

10/8/2015
From Atomic Bomb to Lead and Pollution, Environmental Researchers Celebrate Rich History and Promising Future

From Atomic Bomb to Lead and Pollution, Environmental Researchers Celebrate Rich History and Promising Future

URMC scientists are honoring decades of investigating the impact of environmental exposures on health— dating back to the 1940s when they first looked into the toxicants used in the atomic bomb, to more modern concerns like lead, mercury, air pollution, pesticides, nanomaterials, and epigenetics.

9/17/2015